Corona Remedies IPO: Allotment Date, GMP Trends, And How To Check Status Online
As the bidding for Corona Remedies Ltd's IPO wrapped up after a busy three-day window, investors are now eagerly waiting for the next big milestone, the allotment of shares. With the T+3 listing rule in place, the stock is expected to debut on the Indian exchanges three trading days after closure. This sets the most likely listing date at December 15, 2025, with the allotment expected on December 11, 2025.
Strong Grey Market Sentiment Ahead of Listing
The grey market has reacted enthusiastically following the robust subscription numbers. According to market trackers, Corona Remedies shares are trading at a premium of Rs 270 per share in the grey market today.
This puts the estimated listing price close to Rs 1,332 (Rs 1,062 issue price + Rs 270 GMP), suggesting a healthy 25% potential upside for those who receive allotment.
While GMP is not an official indicator, it often reflects market sentiment and investor appetite ahead of listing.
Where and How to Check Allotment Status
Investors can check whether they have secured shares through two official channels, the BSE website and the registrar, Bigshare Services Private Limited. Both platforms will update the allotment status once the finalisation is completed.
Checking via BSE
- Visit the direct BSE link: com/investors/appli_check Select 'Equity' as the Issue Type Choose 'Corona Remedies Ltd' from the dropdown Enter your application number or PAN Confirm the captcha Click 'Search' to view your allotment status
Checking via Bigshare Services
- Go to bigshareonline Select 'Corona Remedies Ltd' under company name Enter your application number/CAF number, beneficiary ID, or PAN Complete the captcha Click 'Search' to check your status
Once processed, the result will appear instantly on your screen, whether you are checking from a laptop, desktop, or mobile device.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment